Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,520
NCT01714661
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Phase: Phase 3
Role: Collaborator
Start: Oct 31, 2012
Completion: Dec 31, 2015
NCT01716975
Completion: Feb 29, 2016